These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
204 related items for PubMed ID: 14962237
1. Treatment of primary orbital lymphomas. Schick U, Lermen O, Unsöld R, Hassler W. Eur J Haematol; 2004 Mar; 72(3):186-92. PubMed ID: 14962237 [Abstract] [Full Text] [Related]
2. Neurosurgical management of orbital inflammations and infections. Schick U, Hassler W. Acta Neurochir (Wien); 2004 Jun; 146(6):571-80; discussion 580. PubMed ID: 15168225 [Abstract] [Full Text] [Related]
4. Treatment results of tonsillar lymphoma: a 10-year experience. Mohammadianpanah M, Omidvai S, Mosalei A, Ahmadloo N. Ann Hematol; 2005 Apr; 84(4):223-6. PubMed ID: 15042316 [Abstract] [Full Text] [Related]
5. [Primary non-Hodgkin's lymphoma of the nasal cavity at early stage: long-term treatment outcomes and prognostic analyses of 108 cases]. He YF, Zhang YJ, Li YH, Lin TY, Xia YF, Lu TX, Huang HQ, Jiang WQ, Xian CG, He YJ, Guan ZZ. Ai Zheng; 2006 Dec; 25(12):1538-42. PubMed ID: 17166382 [Abstract] [Full Text] [Related]
6. Analysis of local control in patients with non-Hodgkin's lymphoma according to the WHO classification. Sakata K, Satoh M, Someya M, Nagakura H, Oouchi A, Nakata K, Kogawa K, Koito K, Hareyama M, Himi T. Strahlenther Onkol; 2005 Jun; 181(6):385-91. PubMed ID: 15925981 [Abstract] [Full Text] [Related]
7. [Prognosis and treatment strategies of primary B-cell and NK/T-cell nasopharyngeal non-Hodgkin's lymphoma at early stage]. Zou GR, Zhang YJ, Xie FY, Zheng W, Li HX, Xia YF, Lin TY, Lu TX. Ai Zheng; 2006 Dec; 25(12):1543-9. PubMed ID: 17166383 [Abstract] [Full Text] [Related]
8. Diagnostic difficulties and treatment of non-Hodgkin lymphoma of the orbit. Wanyura H, Uliasz M, Kaminski A, Samolczyk-Wanyura D, Smolarz-Wojnowska A. J Craniomaxillofac Surg; 2007 Jan; 35(1):39-47. PubMed ID: 17267230 [Abstract] [Full Text] [Related]
9. Extranodal marginal zone B-cell lymphomas of mucosa-associated lymphoid tissue-type of the orbit and ocular adnexa. Lee JL, Kim MK, Lee KH, Hyun MS, Chung HS, Kim DS, Shin SO, Cho HS, Bae SH, Ryoo HM. Ann Hematol; 2005 Jan; 84(1):13-8. PubMed ID: 15309523 [Abstract] [Full Text] [Related]
10. The therapeutic use of rituximab in non-Hodgkin's lymphoma. Marcus R, Hagenbeek A. Eur J Haematol Suppl; 2007 Jan; (67):5-14. PubMed ID: 17206982 [Abstract] [Full Text] [Related]
11. Management of orbital metastases. Schick U, Lermen O, Hassler W. Zentralbl Neurochir; 2006 Feb; 67(1):1-7. PubMed ID: 16518744 [Abstract] [Full Text] [Related]
12. [Treatment option and outcome for patients with primary non-Hodgkin's lymphoma of the nasal cavity]. Yao B, Li YX, Song YW, Jin J, Liu YP, Wang WH, Wang SL, Sun YT, Yu ZH, Liu XF. Zhonghua Zhong Liu Za Zhi; 2006 Jan; 28(1):58-61. PubMed ID: 16737624 [Abstract] [Full Text] [Related]
13. Indolent stage IE non-Hodgkin's lymphoma of the orbit: results after primary radiotherapy. Bischof M, Zierhut D, Neuhof D, Karagiozidis M, Treiber M, Roeder F, Debus J, Krempien R. Ophthalmologica; 2007 Jan; 221(5):348-52. PubMed ID: 17728558 [Abstract] [Full Text] [Related]
14. [Clinical analysis of 32 primary intestinal non-Hodgkin's lymphoma]. Bai CM, Yang T, Xü Y, Zhang W, Liu XL, Zhu YL, Chen SC, Shen T. Zhonghua Zhong Liu Za Zhi; 2006 Feb; 28(2):142-4. PubMed ID: 16750023 [Abstract] [Full Text] [Related]
15. [Concurrent chemo-radiotherapy for localized refractory non-Hodgkin's lymphoma--report of two cases]. Sugimoto T, Matano S, Nishijima H, Kakuta K, Inamura K, Okamura T, Munemoto S, Satoh S. Gan To Kagaku Ryoho; 2007 Jan; 34(1):125-8. PubMed ID: 17220687 [Abstract] [Full Text] [Related]
16. [Prognostic factors of primary non-Hodgkin's lymphoma of the nasal cavity--a report of 129 cases]. Yao B, Li YX, Fang H, Jin J, Liu XF, Yu ZH. Ai Zheng; 2006 Apr; 25(4):465-70. PubMed ID: 16613682 [Abstract] [Full Text] [Related]
17. Ifosfamide, etoposide, cytarabine, and dexamethasone as salvage treatment followed by high-dose cyclophosphamide, melphalan, and etoposide with autologous peripheral blood stem cell transplantation for relapsed or refractory lymphomas. Schütt P, Passon J, Ebeling P, Welt A, Müller S, Metz K, Moritz T, Seeber S, Nowrousian MR. Eur J Haematol; 2007 Feb; 78(2):93-101. PubMed ID: 17313557 [Abstract] [Full Text] [Related]